表紙
市場調査レポート

アレルギー関連の各種提携契約

Global Allergy Partnering 2010 to 2016

発行 Current Partnering, a division of Wildwood Ventures Limited 商品コード 275316
出版日 ページ情報 英文 150+ Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.51円で換算しております。
Back to Top
アレルギー関連の各種提携契約 Global Allergy Partnering 2010 to 2016
出版日: 2016年02月01日 ページ情報: 英文 150+ Pages
概要

当レポートでは、アレルギー関連の各種提携契約について調査分析し、近年における各種契約の動向、大規模契約および大手医薬品事業者による契約の概要、契約区分・開発ステージ・技術区分別のディレクトリなどをまとめ、概略下記の構成でお届けいたします。

エグゼクティブサマリー

第1章 イントロダクション

第2章 アレルギー関連の各種契約の動向

  • イントロダクション
  • 過去数年におけるアレルギー関連提携
  • 大手製薬会社によるアレルギー関連契約活動
  • アレルギー関連の提携:契約タイプ別
  • アレルギー関連提携の産業市場
  • アレルギー関連の提携:開発段階別
  • アレルギー関連の提携:技術タイプ別
  • 公表されたアレルギー関連の金融契約条件

第3章 主要契約

  • イントロダクション
  • 主要契約:取引額別
  • 大手製薬会社の契約

第4章 契約ディレクトリ

  • イントロダクション
  • 企業 A-Z
  • 契約タイプ別
    • 資産購入
    • 大手製薬会社のアウトライセンシング
    • 共同開発
    • 共同R&D
    • 共同上市
    • サービス契約
    • 共同プロモーション
    • CRADA(共同契約)
    • クロスライセンシング
    • 開発
    • 流通
    • 株式購入
    • 評価
    • 助成金
    • ジョイントベンチャー
    • ライセンシング
    • 製造
    • マーケティング
    • オプション
    • 研究
    • 和解
    • スピンアウト
    • サブライセンス
    • 供給
    • 終了
  • 産業部門別
    • 大学
    • 大手製薬会社
    • バイオテクノロジー
    • 薬剤デリバリー
    • 医療機器
    • 診断
    • ジェネリック医薬品
    • 政府
    • 非営利
    • 医薬品
    • 研究用ツール
    • サービス
    • 特殊医薬品
  • 開発ステージ別
    • 創薬
    • 前臨床
    • フェーズI
    • フェーズII
    • フェーズIII
    • 登録
    • 上市
  • 技術タイプ別
    • 分析
    • 動物モデル
    • アッセイ
    • バイオインフォマティクス
    • 生体化合物
    • バイオマーカー
    • バイオマテリアル
    • 細胞培養
    • 細胞治療
    • 臨床試験
    • 診断:比較
    • 装置
    • 診断
    • 発券ツール
    • DNAプローブ
    • ドラッグデリバリー
    • イネーブリング技術
    • エピジェネティクス
    • 装置
    • 遺伝子治療
    • ゲノミクス
    • 画像
    • 産業用化学品
    • 体外モデル
    • モノクロナール工程
    • ナノテクノロジー
    • オリゴヌクレオチド
    • ペプチド
    • オーダーメイド医療
    • プロセス
    • プロテオミクス
    • 放射性/化学治療
    • 組み換えDNA
    • 研究サービス
    • 研究用備品
    • RNA治療
    • スクリーニング
    • 小分子
    • 幹細胞
    • ワクチン

第5章 契約リソースセンター

  • オンライン提携
  • パートナリングイベント
  • 参考資料

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: CP2224all

Provides understanding and access to the allergy partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.

  • Trends in partnering deals
  • Top deals by value
  • Deals listed by company A-Z, industry sector, stage of development, technology type

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains multiple links to online copies of actual bladder cancer deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of partnering trends.

Chapter 1 provides an overview of the trends in partnering since 2010, including a summary of deals by industry sector, stage of development, deal type, and technology type.

Chapter 2 provides a review of the top 10 most active companies in the therapy area, including a comprehensive listing of the deals announced by each company.

Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2010. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links via Weblink to an online version of the deal record, and where available the contract document, providing easy access to each contract document on demand.

Chapter 4 provides a listing of partnering deals where a contract document is available alongside the deal record.

Chapters 5 and 6 provide a summary of M&A deals since 2010 where the acquired company is active in the therapy area of interest.

Chapters 7 and 8 provide a summary of financings since 2010 where the financed company is active in the therapy area of interest.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products in the therapy area.

Benefits

Global Therapy Partnering Terms and Agreements since 2010 report provides the reader with the following key benefits:

  • In-depth understanding of deal trends since 2010
  • Access to headline, upfront, milestone and royalty data
  • Comprehensive access to multiple deals entered into by the world's biopharma companies since 2010
  • Insight into key deal terms included in contracts, where disclosed
  • Understand the key deal terms companies have agreed in deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Table of Contents

Executive Summary

Chapter 1 - Therapypartnering trends in numbers

  • Partnering in numbers - by year
  • Partnering in numbers - most active
  • Partnering in numbers - by industry sector
  • Partnering in numbers - by deal type
  • Partnering in numbers - by technology type
  • Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory

  • Partnering deals directory - by company A-Z
  • Partnering deals directory - by deal value
  • Partnering deals directory - by industry sector
  • Partnering deals directory - by deal type
  • Partnering deals directory - by stage of development
  • Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document

Chapter 5 - M&A in numbers

  • M&A in numbers - by year

Chapter 6 - M&A deals directory

  • M&A deals directory - by company A-Z
  • M&A deals directory - by deal value

Chapter 7 - Financing in numbers

  • Financing in numbers - by year
  • Financing in numbers - by financing type

Chapter 8 - Financing deals directory

  • Financing deals directory - by company A-Z
  • Financing deals directory - by deal value
  • Financing deals directory - by financing type
  • About Wildwood Ventures
  • Current Partnering
  • Current Agreements
  • Recent titles from CurrentPartnering

TABLE OF FIGURES

  • Figure 1: Partnering frequency by year
  • Figure 2: Partnering most active
  • Figure 3: Partnering by industry sector
  • Figure 4: Partnering by deal type
  • Figure 5: Partnering by technology area
  • Figure 6: Partnering by stage of development
  • Figure 7: M&A frequency by year
  • Figure 8: Financing frequency by year
  • Figure 9: Financing by type
Back to Top